Private company

Immunomedics (United States)

Former pharmaceutical company

Immunomedics was a biotechnology company focused on the development of antibody-drug conjugates for the treatment of cancer. In 2020, the company was acquired by Gilead Sciences for $21 billion.2 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

1982Founded1

Immunomedics was a biotechnology company focused on the development of antibody-drug conjugates for the treatment of cancer. In 2020, the company was acquired by Gilead Sciences for $21 billion.2

Corporate structure

Immunomedics (United States) sits at the top of its group. 2 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

  • Immunomedics (United States) Morris Plains
    • Immunomedics (Germany) Subsidiary ยท Germany

Built from subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

Subsidiaries and ownership

Subsidiaries

  • Immunomedics (Germany)

From Wikidata.1

Timeline

  1. 1982Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2